PDK1 and breast carcinoma: As multiple kinases have been implicated as substrates of PDK1 [14], it is also likely that a PDK1 inhibitor, such as PF-5177624, would block IGF-I induced cell transformation by inhibiting multiple PDK1 substrates collaboratively in breast cancer cells.